Authors: RISLER EA SWEATMAN T NACKERUD L

Citation: Ea. Risler et al., EVALUATING THE GEORGIA LEGISLATIVE WAIVERS EFFECTIVENESS IN DETERRINGJUVENILE CRIME, Research on social work practice, 8(6), 1998, pp. 657-667

Authors: PARKER SL PARKER MS SWEATMAN T CROWLEY WR

Citation: Sl. Parker et al., CHARACTERIZATION OF G-PROTEIN AND PHOSPHOLIPASE C-COUPLED AGONIST BINDING TO THE Y-1 NEUROPEPTIDE-Y RECEPTOR IN RAT-BRAIN - SENSITIVITY TO G-PROTEIN ACTIVATORS AND INHIBITORS AND TO INHIBITORS OF PHOSPHOLIPASEC-1,C-2, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 382-391

Authors: GREENBERG RE BAHNSON RR WOOD D CHILDS SJ BELLINGHAM C EDSON M BAMBERGER MH STEINBERG GD ISRAEL M SWEATMAN T GIANTONIO B ODWYER PJ

Citation: Re. Greenberg et al., INITIAL REPORT ON INTRAVESICAL ADMINISTRATION OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD-32) TO PATIENTS WITH REFRACTORY SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER, Urology, 49(3), 1997, pp. 471-475

Authors: MARKMAN M HOMESLEY H NORBERTS DA SCHINK J ABBAS F MILLER A SOPER J TENG N HAMMOND N MUGGIA F ISRAEL M SWEATMAN T

Citation: M. Markman et al., PHASE-1 TRIAL OF INTRAPERITONEAL AD-32 IN GYNECOLOGIC MALIGNANCIES, Gynecologic oncology, 61(1), 1996, pp. 90-93